• CoronaCoronavirus (COVID-19) Resources

    In an effort to support our members with the most updated information on COVID-19 we developed this resource page to easily access current CDC information and other resources to assist you professionally and personally.

    We will continue to update this page with more information as it becomes available and welcome your input as we navigate through this situation. As health care professionals it is our job to educate our patients and families on prevention and the what to do if someone is symptomatic.

    View resources


  • 2020 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsGAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    Rescheduled, so you won't miss a thing! Find out what to do next!

    April 20-24, 2021, Honolulu, Hawaii

    More Information

  • AwardCall for Excellence Award Nominations

    The awards are: Emerging Chapter Award, Established Chapter Excellence Award, Special Interest Group Excellence Award, Excellence in Clinical Practice Award, Excellence in Community Service Award, Excellence in Education Award, Excellence in Leadership Award, and Excellence in Research Award.

    The nominations are tallied in July and the winners are announced every year during the Awards Celebration at the GAPNA Annual Conference.

    Now is the time to nominate a colleague or yourself - DEADLINE is June 1, 2020.

    Get started... nominate today!

  • FREE CE for GAPNA MembersFREE continuing education credit is available for the following session:

    "Safety and Utility of Cannabis in the Elderly"

    (session captured at the GAPNA 2018 Annual Conference)

    For March/April 2020 - Get Your Free CNE Now!

Antipsychotic Choices in Nursing Homes Partly Influenced by Nursing Home’s Prescribing Culture

A new study reveals the majority of nursing homes favor treating patients with atypical antipsychotics.

Using a variety of data sources, including Medicaid and Medicare data, the researchers identified 65,618 patients 65 years or older residing in nursing homes in 45 states.

All had started treatment with an antipsychotic after their admission between 2001 and 2005.

Nearly half of the nursing homes studied (45%) never prescribed a conventional antipsychotic medication.

In fact, 91.2% of patients started treatment with an atypical medication. Of the 8.8% of patients treated with a conventional medication, the most frequently prescribed drugs were haloperidol (86%) and chlorpromazine (8%).

See the complete study at Huybrechts, K.F. et al. (2012). Variation in antipsychotic treatment choice across US nursing homes. Journal of Clinical Psychopharmacology, 32(1), 11-17.

Related Topic 1: 

GAPNA Newsletter Issue: